ANASTROZOLE ERIS anastrozole 1 mg film-coated tablet blister pack

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

anastrozole, Quantity: 1 mg

Disponível em:

Strides Pharma Science Pty Ltd

DCI (Denominação Comum Internacional):

Anastrozole

Forma farmacêutica:

Tablet, film coated

Composição:

Excipient Ingredients: sodium starch glycollate; lactose monohydrate; hypromellose; magnesium stearate; povidone; titanium dioxide; macrogol 400

Via de administração:

Oral

Unidades em pacote:

30 tablets

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

First line treatment of advanced breast cancer in postmenopausal women with oestrogen/progesterone receptor positive disease. Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with oestrogen receptor negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to ANASTROZOLE ERIS.

Resumo do produto:

Visual Identification: White to off-white, round, biconvex film coated tablet engraved with the letters "A 1" on one side and plain on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Status de autorização:

Licence status A

Data de autorização:

2012-09-24